SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030036
Filing Date
2019-08-07
Accepted
2019-08-07 16:02:42
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q derm-10q_20190630.htm 10-Q 2422482
2 EX-31.1 derm-ex311_10.htm EX-31.1 16926
3 EX-31.2 derm-ex312_6.htm EX-31.2 17591
4 EX-32.1 derm-ex321_7.htm EX-32.1 5772
5 EX-32.2 derm-ex322_9.htm EX-32.2 6400
  Complete submission text file 0001564590-19-030036.txt   6845655

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT derm-20190630.xml EX-101.INS 1177353
7 XBRL TAXONOMY EXTENSION SCHEMA derm-20190630.xsd EX-101.SCH 52577
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE derm-20190630_cal.xml EX-101.CAL 56791
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE derm-20190630_def.xml EX-101.DEF 205350
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE derm-20190630_lab.xml EX-101.LAB 425130
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE derm-20190630_pre.xml EX-101.PRE 325202
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

IRS No.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36668 | Film No.: 191005399
SIC: 2834 Pharmaceutical Preparations